The W1 tenure-track Junior Professorship was globally advertised in July 2017 and no less than 42 applications were received, with 22 from international research institutions, including candidates from Oxford, Cambridge, Harvard University, Rockefeller University and EMBL.
Subsequently, a select group of eight promising talents was invited to present their research at a symposium on 29th November 2017. After an extensive debate within the recruitment committee a shortlist with four candidates was agreed upon and external reviewers asked to submit reports on the remaining candidates. Dr. Michael Böttcher, an internationally recognized expert in CRISPR dissection of cancer signaling networks, accepted the junior professorship offer in December 2018, starting his independent research group in April 2019. It is based in the Charles Tanford Protein Research Center.
Michael Böttcher studied Molecular Biology in Freiburg, Germany, and conducted research for his Diploma thesis at ACPFG inAdelaide, Australia. His PhD research and a first postdoc were done at the German Cancer Research Center (DKFZ) in Heidelberg, followed by a second postdoc at UCSF (Michael McManus group; San Francisco, CA, USA). Returning to Germany, Michael Böttcher became a senior researcher at the Max-Planck Institute in Berlin, initially as a member of the Hans Lehrach laboratory and subsequently of Emanuelle Charpentier’s group. His main research focus is on the dissection of cancer genetic networks utilizing, for example, CRISPR-based technologies.